Filing Details
- Accession Number:
- 0001127602-16-039363
- Form Type:
- 4
- Zero Holdings:
- No
- Publication Time:
- 2016-02-03 17:43:11
- Reporting Period:
- 2016-02-01
- Filing Date:
- 2016-02-03
- Accepted Time:
- 2016-02-03 17:43:11
- SEC Url:
- Form 4 Filing
Issuer
| Cik | Name | Symbol | Sector (SIC) | IRS No |
|---|---|---|---|---|
| 884731 | Ariad Pharmaceuticals Inc | ARIA | Biological Products, (No Disgnostic Substances) (2836) | 223106987 |
Insiders
| Cik | Name | Reported Address | Insider Title | Director | Officer | Large Shareholder | Other |
|---|---|---|---|---|---|---|---|
| 1662996 | Paris Panayiotopoulos | 26 Landsdowne Street Cambridge MA 02139 | President And Ceo | Yes | Yes | No | No |
Reported Non-Derivative Transactions
| Sec. Name | Acquisiton - Disposition | Date | Amount | Price | Remaning Holdings | Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|---|---|---|---|---|---|
| Common Stock | Acquisiton | 2016-02-01 | 61,099 | $4.91 | 61,099 | No | 4 | P | Direct |
| Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|
| No | 4 | P | Direct |
Footnotes
- The purchase was made pursuant to the terms of his employment agreement, as summarized in the Current Report on Form 8-K filed on December 18, 2015.
Billionaire Hedge Funds
